Five years on, long COVID’s clinical picture is sharpening, revealing persistent lung changes, immune dysregulation, and a ...

For healthtech leaders building, buying or investing in platforms, the question is how to operate against a moving risk ...

Researchers conducted a pooled analysis of individual patient-level data from 15 trials assessing time to colon ...

Researchers have indicated in a new study that a COPD Assessment Test-based definition of chronic bronchitis (CAT-CB) is more ...

IRCCS Ospedale Policlinico San Martino with Mayo Clinic and multiple international cancer research centers have delivered a ...

Learn how the Economic Value of Equity (EVE) helps banks manage assets, understand interest rate risks, and its limitations ...

Pastorino and colleagues noted that defining cure in stage II and III colon cancer has been challenging for two reasons: It ...

Amendments to the International Health Regulations (IHR) effective September 19, 2025, aim to protect global health security.

Seth Goldstein, a Morningstar analyst who tracks Tesla, said its valuation could easily hit $3 trillion or more over a decade ...

Colon cancer recurrence risk falls below 0.5% at 6 years post-surgery, offering a practical benchmark for defining cure, according to new research.

If you opt for only low-risk investments, you’re likely to lose purchasing power over time. It’s also why low-risk plays make ...

Invesco Dorsey Wright Developed Markets Momentum ETF's high turnover, portfolio concentration, and expensive valuation ...